Five of the top 10 pharmaceutical companies in the world trust ReactWise

Five of the top 10 pharmaceutical companies in the world trust ReactWise.

For years, chemistry R&D teams have stitched together several separate tools: One for HTE plate design. One for reaction optimization. One for kinetic modeling. One for solvent selection. One for visualization. 

Each with its own access, its own data format, and data being moved between them using csv files.

That fragmented approach is losing.

The market is consolidating around platforms that do the whole job, not just one piece of it. 

ReactWise starts at HTE plate design for hit screening for both discovery and process chemistry. From there, it moves into advanced data-driven optimization, powered by transfer learning and Bayesian optimization that gets smarter with every historical campaign. 

Underneath that sits genuine chemical reasoning, not just statistics, grounded in our chemical descriptor databases that understand molecules, not just numbers in a spreadsheet.

When you need mechanistic understanding, first-principles kinetic models reveal what's actually driving your reaction, not just what correlates with it.

And when sustainability and scalability matter, our solvent-swap engine identifies single or binary solvent replacements that eliminate toxic, non-scalable choices, without sacrificing the chemistry that made the original conditions work.

All of it. One platform.

The fragmented era of chemistry R&D software is ending. The biggest names in pharma are voting with their chemistry.

‍